Archive for the ‘cardiology retractions’ Category
On Tuesday, we broke the news of the retraction in Circulation of a paper on cardiac stem cells by a group of researchers being investigated by Harvard Medical School and the Brigham and Women’s Hospital. Today, The Lancet has issued an Expression of Concern about another paper led by Piero Anversa, the last author of the Circulation paper.
Circulation has retracted a 2012 study by a group of Harvard heart specialists over concerns of corrupt data, and the university is investigating. The group was led by Piero Anversa, a leading cardiologist, and Joseph Loscalzo — who will be familiar to readers of Circulation as the editor in chief of that journal. (Anversa’s also on the editorial board).
The International Journal of Cardiovascular Imaging has retracted a 2013 paper by a group of researchers from Italy. The reason: plagiarism.
The paper was titled “Diagnostic accuracy of 320-row computed tomography as compared with invasive coronary angiography in unselected, consecutive patients with suspected coronary artery disease,” and it came from scientists in Rome led by Francesco Pelliccia of the Department of Heart and Great Vessels at Sapienza University.
Follow this timeline, if you would:
- August 14, 2013: Former UConn researcher Dipak Das, who was found to have committed misconduct, submits a paper to Oxidative Medicine and Cellular Longevity.
- September 19, 2013: Das dies.
- October 17, 2013: Das submits revisions to his paper in Oxidative Medicine and Cellular Longevity.
- October 18, 2013: Paper accepted.
- January 12, 2014: Paper published.
That would appear to be what the timeline on the paper — which lists Das as corresponding author, along with a Gmail address — says:
Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.
Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”
Here’s the notice, for “Dynamic Action of Carotenoids in Cardioprotection and Maintenance of Cardiac Health,” from Molecules:
We have an update on the case of Parag Patel, the Park Ridge, Illinois cardiologist whom the Office of Research Integrity (ORI) said “engaged in research misconduct by directing or intimidating fellows and others to influence” test results so that patients would be eligible for a clinical trial.
A spokesperson for the clinical trial’s sponsor, the University of California, San Francisco (UCSF), tells us: Read the rest of this entry »
A cardiology researcher in Illinois coerced trainees to fake the results of a heart test so that patients would qualify to enter a clinical trial, according to a new finding by the Office of Research Integrity (ORI).
Jeffrey Beall, a scholarly librarian perhaps known best for his list of possible predatory journals, has convinced one of those journals to retract a paper for plagiarism.